non-Alzheimer's dementia

non-Alzheimer's dementia

A general term for any form of dementia other than Alzheimer’s disease.

Aetiology, non-Alzheimer’s dementia
Dementia
• Lewy body dementia
• Spongiform encephalopathy
    -External causes
      • Infection (e.g., HIV)
      • Metabolic
      • Nutritional
      • Toxins
      • Trauma (e.g., dementia pugilistica)
Hereditary dementia of early- or later- (e.g., Huntington’s disease) onset
Hydrocephalus
Mass lesions (e.g., tumours)
Vascular disease
White matter disease
References in periodicals archive ?
One study in Mexico took skin biopsies from patients with Alzheimer's, Parkinson's and non-Alzheimer's dementia as well as similarly aged healthy patients and used immunohistochemistry (IHC) tests to assay levels of tau protein.
And the inclusion of patients with "mild Alzheimer's," who probably had non-Alzheimer's dementia, may have tainted the study pool and subsequent results of both trials.
The researchers found no association between cancer history and reduced risk of any other typical age-related health outcome; in fact, most cancer survivors were found to be at increased risk for non-Alzheimer's dementia.
A total of 632 (9 percent) participants developed dementia over the 8 subsequent years of follow-up, among them 284 probable AD and 228 possible AD, and the remaining 120 non-Alzheimer's dementia.
The results of this study may not be applicable to primary-care settings, to individuals whose depression is severe, to non-Alzheimer's dementia, or even to other antidepressant drugs other than sertraline and mirtazapine.
At UCSF's MAC, researchers required video documentation of elusive symptoms to help standardize the diagnosis of non-Alzheimer's dementia.
Most cancer survivors were also at increased risk for non-Alzheimer's dementia.
42] have had their diagnoses changed to no dementia or non-Alzheimer's dementia.
Previous studies had suggested that naMCI, which is a precursor of vascular and non-Alzheimer's dementias, has a vascular origin.
That ratio was calculated to be 74 for people with non-Alzheimer's dementias and 48 for those with other brain disorders.
The results have shown that this group of biomarkers is useful in the differential diagnosis of Alzheimer's disease (AD) from normal control individuals, patients with non-Alzheimer's dementias, and patients with Parkinson's disease or ALS (Lou Gehrig's disease).
We believe this Power3 discovered biomarker will be useful in the differential diagnosis of Alzheimer's disease from normal (control) individuals and patients with non-Alzheimer's dementias," he said.
Full browser ?